BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 32898135)

  • 1. A combination of 7-ketocholesterol, lysosphingomyelin and bile acid-408 to diagnose Niemann-Pick disease type C using LC-MS/MS.
    Wu C; Iwamoto T; Hossain MA; Akiyama K; Igarashi J; Miyajima T; Eto Y
    PLoS One; 2020; 15(9):e0238624. PubMed ID: 32898135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitation of plasmatic lysosphingomyelin and lysosphingomyelin-509 for differential screening of Niemann-Pick A/B and C diseases.
    Kuchar L; Sikora J; Gulinello ME; Poupetova H; Lugowska A; Malinova V; Jahnova H; Asfaw B; Ledvinova J
    Anal Biochem; 2017 May; 525():73-77. PubMed ID: 28259515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of niemann-pick C1 by measurement of bile acid biomarkers in archived newborn dried blood spots.
    Jiang X; Sidhu R; Orsini JJ; Farhat NY; Porter FD; Berry-Kravis E; Schaffer JE; Ory DS
    Mol Genet Metab; 2019 Feb; 126(2):183-187. PubMed ID: 30172462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma lysosphingomyelin demonstrates great potential as a diagnostic biomarker for Niemann-Pick disease type C in a retrospective study.
    Welford RW; Garzotti M; Marques Lourenço C; Mengel E; Marquardt T; Reunert J; Amraoui Y; Kolb SA; Morand O; Groenen P
    PLoS One; 2014; 9(12):e114669. PubMed ID: 25479233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic tests for Niemann-Pick disease type C (NP-C): A critical review.
    Vanier MT; Gissen P; Bauer P; Coll MJ; Burlina A; Hendriksz CJ; Latour P; Goizet C; Welford RW; Marquardt T; Kolb SA
    Mol Genet Metab; 2016 Aug; 118(4):244-54. PubMed ID: 27339554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of 7-ketocholesterol in plasma by LC-MS for rapid diagnosis of acid SMase-deficient Niemann-Pick disease.
    Lin N; Zhang H; Qiu W; Ye J; Han L; Wang Y; Gu X
    J Lipid Res; 2014 Feb; 55(2):338-43. PubMed ID: 24190732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of a glycinated bile acid biomarker for diagnosis and assessment of response to treatment in Niemann-pick disease type C1.
    Sidhu R; Kell P; Dietzen DJ; Farhat NY; Do AND; Porter FD; Berry-Kravis E; Reunert J; Marquardt T; Giugliani R; Lourenço CM; Wang RY; Movsesyan N; Plummer E; Schaffer JE; Ory DS; Jiang X
    Mol Genet Metab; 2020 Dec; 131(4):405-417. PubMed ID: 33257258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholestane-3β,5α,6β-triol: high levels in Niemann-Pick type C, cerebrotendinous xanthomatosis, and lysosomal acid lipase deficiency.
    Pajares S; Arias A; García-Villoria J; Macías-Vidal J; Ros E; de las Heras J; Girós M; Coll MJ; Ribes A
    J Lipid Res; 2015 Oct; 56(10):1926-35. PubMed ID: 26239048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of lysosphingomyelin and lysosphingomyelin-509 for the screening of acid sphingomyelinase deficiency.
    Kubaski F; Burlina A; Pereira D; Silva C; Herbst ZM; Trapp FB; Michelin-Tirelli K; Lopes FF; Burin MG; Brusius-Facchin AC; Netto ABO; Poletto E; Bernardes TM; Carvalho GS; Sorte NB; Ferreira FN; Perin N; Clivati MR; de Santana MTS; Lobos SFG; Leão EKEA; Coutinho MP; Pinos PV; Santos MLSF; Penatti DA; Lourenço CM; Polo G; Giugliani R
    Orphanet J Rare Dis; 2022 Nov; 17(1):407. PubMed ID: 36348386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of N-palmitoyl-O-phosphocholineserine for diagnosis and assessment of response to treatment in Niemann-Pick type C disease.
    Sidhu R; Kell P; Dietzen DJ; Farhat NY; Do AND; Porter FD; Berry-Kravis E; Vite CH; Reunert J; Marquardt T; Giugliani R; Lourenço CM; Bodamer O; Wang RY; Plummer E; Schaffer JE; Ory DS; Jiang X
    Mol Genet Metab; 2020 Apr; 129(4):292-302. PubMed ID: 32033912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a bile acid-based newborn screen for Niemann-Pick disease type C.
    Jiang X; Sidhu R; Mydock-McGrane L; Hsu FF; Covey DF; Scherrer DE; Earley B; Gale SE; Farhat NY; Porter FD; Dietzen DJ; Orsini JJ; Berry-Kravis E; Zhang X; Reunert J; Marquardt T; Runz H; Giugliani R; Schaffer JE; Ory DS
    Sci Transl Med; 2016 May; 8(337):337ra63. PubMed ID: 27147587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High level of oxysterols in neonatal cholestasis: a pitfall in analysis of biochemical markers for Niemann-Pick type C disease.
    Polo G; Burlina A; Furlan F; Kolamunnage T; Cananzi M; Giordano L; Zaninotto M; Plebani M; Burlina A
    Clin Chem Lab Med; 2016 Jul; 54(7):1221-9. PubMed ID: 26650075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LC-MS/MS based assay and reference intervals in children and adolescents for oxysterols elevated in Niemann-Pick diseases.
    Klinke G; Rohrbach M; Giugliani R; Burda P; Baumgartner MR; Tran C; Gautschi M; Mathis D; Hersberger M
    Clin Biochem; 2015 Jun; 48(9):596-602. PubMed ID: 25819840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new simple and rapid LC-ESI-MS/MS method for quantification of plasma oxysterols as dimethylaminobutyrate esters. Its successful use for the diagnosis of Niemann-Pick type C disease.
    Boenzi S; Deodato F; Taurisano R; Martinelli D; Verrigni D; Carrozzo R; Bertini E; Pastore A; Dionisi-Vici C; Johnson DW
    Clin Chim Acta; 2014 Nov; 437():93-100. PubMed ID: 25038260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of novel bile acids as biomarkers for the early diagnosis of Niemann-Pick C disease.
    Mazzacuva F; Mills P; Mills K; Camuzeaux S; Gissen P; Nicoli ER; Wassif C; Te Vruchte D; Porter FD; Maekawa M; Mano N; Iida T; Platt F; Clayton PT
    FEBS Lett; 2016 Jun; 590(11):1651-62. PubMed ID: 27139891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural Determination of Lysosphingomyelin-509 and Discovery of Novel Class Lipids from Patients with Niemann-Pick Disease Type C.
    Maekawa M; Jinnoh I; Matsumoto Y; Narita A; Mashima R; Takahashi H; Iwahori A; Saigusa D; Fujii K; Abe A; Higaki K; Yamauchi S; Ozeki Y; Shimoda K; Tomioka Y; Okuyama T; Eto Y; Ohno K; T Clayton P; Yamaguchi H; Mano N
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31658747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Blood 7-ketocholesterol level, clinical features and gene mutation analysis of 18 children with Niemann-Pick disease type C].
    Zhan X; Lin N; Zhang HW; Gao XL; Qiu WJ; Han LS; Ye J; Gu XF
    Zhonghua Er Ke Za Zhi; 2016 Jun; 54(6):419-23. PubMed ID: 27256227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A sensitive and specific LC-MS/MS method for rapid diagnosis of Niemann-Pick C1 disease from human plasma.
    Jiang X; Sidhu R; Porter FD; Yanjanin NM; Speak AO; te Vruchte DT; Platt FM; Fujiwara H; Scherrer DE; Zhang J; Dietzen DJ; Schaffer JE; Ory DS
    J Lipid Res; 2011 Jul; 52(7):1435-45. PubMed ID: 21518695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive Evaluation of Plasma 7-Ketocholesterol and Cholestan-3β,5α,6β-Triol in an Italian Cohort of Patients Affected by Niemann-Pick Disease due to NPC1 and SMPD1 Mutations.
    Romanello M; Zampieri S; Bortolotti N; Deroma L; Sechi A; Fiumara A; Parini R; Borroni B; Brancati F; Bruni A; Russo CV; Bordugo A; Bembi B; Dardis A
    Clin Chim Acta; 2016 Apr; 455():39-45. PubMed ID: 26790753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of biomarkers analysis in the diagnosis of Niemann-Pick C disease and acid sphingomyelinase deficiency.
    Deodato F; Boenzi S; Taurisano R; Semeraro M; Sacchetti E; Carrozzo R; Dionisi-Vici C
    Clin Chim Acta; 2018 Nov; 486():387-394. PubMed ID: 30153451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.